SYNLAB Balance Sheet Health

Financial Health criteria checks 4/6

SYNLAB has a total shareholder equity of €2.4B and total debt of €924.8M, which brings its debt-to-equity ratio to 39%. Its total assets and total liabilities are €4.7B and €2.3B respectively. SYNLAB's EBIT is €151.2M making its interest coverage ratio 1.8. It has cash and short-term investments of €300.5M.

Key information

39.0%

Debt to equity ratio

€924.83m

Debt

Interest coverage ratio1.8x
Cash€300.47m
Equity€2.37b
Total liabilities€2.34b
Total assets€4.71b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: SYAB's short term assets (€860.3M) exceed its short term liabilities (€693.9M).

Long Term Liabilities: SYAB's short term assets (€860.3M) do not cover its long term liabilities (€1.6B).


Debt to Equity History and Analysis

Debt Level: SYAB's net debt to equity ratio (26.3%) is considered satisfactory.

Reducing Debt: SYAB's debt to equity ratio has reduced from 248.8% to 39% over the past 5 years.

Debt Coverage: SYAB's debt is well covered by operating cash flow (45.3%).

Interest Coverage: SYAB's interest payments on its debt are not well covered by EBIT (1.8x coverage).


Balance Sheet


Discover healthy companies